Bodycote (BYPLF)
(Delayed Data from OTC)
$9.28 USD
0.00 (0.00%)
Updated Jul 17, 2024 01:37 PM ET
3-Hold of 5 3
C Value B Growth NA Momentum NA VGM
Balance Sheet
Fiscal Year End for Bodycote falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 56 | 46 | 55 | 39 | 28 |
Receivables | 201 | 221 | 189 | 176 | 203 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 37 | 34 | 27 | 20 | 19 |
Other Current Assets | 1 | 0 | 1 | 4 | 0 |
Total Current Assets | 294 | 302 | 271 | 239 | 250 |
Net Property & Equipment | 628 | 639 | 673 | 671 | 683 |
Investments & Advances | 0 | 0 | 0 | 5 | 5 |
Other Non-Current Assets | 2 | 2 | 2 | 3 | 2 |
Deferred Charges | 3 | 2 | 3 | 3 | 8 |
Intangibles | 414 | 426 | 443 | 415 | 271 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 1,414 | 1,444 | 1,471 | 1,425 | 1,312 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 153 | 154 | 151 | 219 | 163 |
Current Portion Long-Term Debt | 41 | 87 | 126 | 68 | 1 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 57 | 53 | 47 | 39 | 40 |
Other Current Liabilities | 15 | 13 | 20 | 33 | 5 |
Total Current Liabilities | 280 | 323 | 362 | 378 | 226 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 64 | 63 | 65 | 55 | 62 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 19 | 25 | 31 | 38 | 38 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 428 | 477 | 529 | 550 | 410 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 41 | 41 | 46 | 43 | 42 |
Capital Surplus | 220 | 219 | 244 | 227 | 226 |
Retained Earnings | 503 | 445 | 439 | 394 | 424 |
Other Equity | 241 | 269 | 223 | 220 | 224 |
Treasury Stock | 19 | 6 | 9 | 9 | 15 |
Total Shareholder's Equity | 986 | 967 | 942 | 875 | 901 |
Total Liabilities & Shareholder's Equity | 1,414 | 1,444 | 1,471 | 1,425 | 1,312 |
Total Common Equity | 986 | 967 | 942 | 875 | 901 |
Shares Outstanding | NA | NA | 191.40 | 191.40 | 191.40 |
Book Value Per Share | -0.01 | -0.01 | 4.92 | 4.57 | 4.71 |
Fiscal Year End for Bodycote falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | -99,999 | 56 | -99,999 | -99,967 |
Receivables | NA | NA | 201 | NA | 225 |
Notes Receivable | NA | NA | 0 | NA | NA |
Inventories | NA | NA | 37 | NA | 36 |
Other Current Assets | NA | NA | 1 | NA | NA |
Total Current Assets | NA | NA | 294 | NA | 293 |
Net Property & Equipment | NA | NA | 628 | NA | 620 |
Investments & Advances | NA | NA | 0 | NA | NA |
Other Non-Current Assets | NA | NA | 2 | NA | 2 |
Deferred Charges | NA | NA | 3 | NA | 3 |
Intangibles | NA | NA | 414 | NA | 416 |
Deposits & Other Assets | NA | NA | 0 | NA | NA |
Total Assets | NA | NA | 1,414 | NA | 1,404 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | NA | 0 | NA | NA |
Accounts Payable | NA | NA | 153 | NA | 159 |
Current Portion Long-Term Debt | NA | NA | 41 | NA | 66 |
Current Portion Capital Leases | NA | NA | 0 | NA | NA |
Accrued Expenses | NA | NA | 0 | NA | NA |
Income Taxes Payable | NA | NA | 57 | NA | 58 |
Other Current Liabilities | NA | NA | 15 | NA | 12 |
Total Current Liabilities | NA | NA | 280 | NA | 309 |
Mortgages | NA | NA | 0 | NA | NA |
Deferred Taxes/Income | NA | NA | 64 | NA | 61 |
Convertible Debt | NA | NA | 0 | NA | NA |
Long-Term Debt | NA | NA | 0 | NA | NA |
Non-Current Capital Leases | NA | NA | 0 | NA | NA |
Other Non-Current Liabilities | NA | 19 | NA | 24 | |
Minority Interest (Liabilities) | NA | NA | 0 | NA | NA |
Total Liabilities | NA | NA | 428 | NA | 457 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | NA | 0 | NA | NA |
Common Stock (Par) | NA | NA | 41 | NA | 41 |
Capital Surplus | NA | NA | 220 | NA | 222 |
Retained Earnings | NA | NA | 503 | NA | 467 |
Other Equity | NA | NA | 241 | NA | 235 |
Treasury Stock | NA | NA | 19 | NA | 18 |
Total Shareholder's Equity | NA | NA | 986 | NA | 947 |
Total Liabilities & Shareholder's Equity | NA | NA | 1,414 | NA | 1,404 |
Total Common Equity | 0 | 0 | 986 | 0 | 100,946 |
Shares Outstanding | NA | NA | NA | NA | NA |
Book Value Per Share | 0.00 | 0.00 | -0.01 | 0.00 | -1.01 |